Effects of G-CSF in Treatment of Acute Myocardial Infarction in Rats
Jin Peng
Abstract
Jin Peng
Abstract
Objective:To investigate the effects of granulocyte colony-stimulating factor(G-CSF) mobilizing bone stem cells in treatment of acute myocardial infarction(AMI) in rats.Methods:32 SD masculine rats were randomly divided into 2 groups(every group possess 16 rats) after injected isoproterenol(ISO) and created AMI model.A group:G-CSF group,B group:control group.Every group was randomly divided into 2 subgroups.Hearts of every group was measured ventricle function and simultaneity weighted the heart after 2 weeks and 4 weeks.HE stain was used to detect the myocardial infarction areas.Results:(1)14 days after ISO ①the left ventricle function:in group A,the LVSP、LVEDP、±dp/dt were higher than B group(P0.05);②the weight of left ventricle:in group A,the weight of heart/avoirdupois of rat was less than B group(P0.05);③the myocardial infarction areas:in group A,the myocardial infarction areas/the left ventricle overall areas was less than B group(P0.05);(2)In group A and B,there were the same results for 28 days comparing with for 14 days after injecting ISO.(3)the results of comparing between subgroups ①In A group,the ventricle function in the 4 weeks subgroup was higher than in the 2 weeks subgroup(P0.05),the myocardial infarction areas in the 4 weeks subgroup were smaller than in the 2 weeks subgroup(P0.05).The remodification of ventricle was not significant.②In B group,there were not significance difference of ventricle function、myocardial infarction areas and remodification of the left ventricle between subgroups.There was not statistics significance difference of heart rate between groups.Conclusions:G-CSF can protect and rebirth the ischemiced cardiac muscle of acute myocardial infarction in the rat models and improve the ventricle function in rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of granulocyte colony-stimulating factor(G-CSF) mobilizing bone stem cells in treatment of acute myocardial infarction(AMI) in rats.Methods:32 SD masculine rats were randomly divided into 2 groups(every group possess 16 rats) after injected isoproterenol(ISO) and created AMI model.A group:G-CSF group,B group:control group.Every group was randomly divided into 2 subgroups.Hearts of every group was measured ventricle function and simultaneity weighted the heart after 2 weeks and 4 weeks.HE stain was used to detect the myocardial infarction areas.Results:(1)14 days after ISO ①the left ventricle function:in group A,the LVSP、LVEDP、±dp/dt were higher than B group(P0.05);②the weight of left ventricle:in group A,the weight of heart/avoirdupois of rat was less than B group(P0.05);③the myocardial infarction areas:in group A,the myocardial infarction areas/the left ventricle overall areas was less than B group(P0.05);(2)In group A and B,there were the same results for 28 days comparing with for 14 days after injecting ISO.(3)the results of comparing between subgroups ①In A group,the ventricle function in the 4 weeks subgroup was higher than in the 2 weeks subgroup(P0.05),the myocardial infarction areas in the 4 weeks subgroup were smaller than in the 2 weeks subgroup(P0.05).The remodification of ventricle was not significant.②In B group,there were not significance difference of ventricle function、myocardial infarction areas and remodification of the left ventricle between subgroups.There was not statistics significance difference of heart rate between groups.Conclusions:G-CSF can protect and rebirth the ischemiced cardiac muscle of acute myocardial infarction in the rat models and improve the ventricle function in rats.
Key concepts: Ventricle, Medicine, Myocardial infarction, Preload, Internal medicine, Group B, Cardiology, Infarction